Chiara Castelli Department of Experimental Oncology and Molecular Medicine, Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy
1 protocol

Francesca Rini Department of Experimental Oncology and Molecular Medicine, Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy
1 protocol

Valeria Beretta Department of Experimental Oncology and Molecular Medicine, Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy
1 protocol

Alessandra Tuccitto Department of Experimental Oncology and Molecular Medicine, Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy
1 protocol
Alessandro Didonna University of California, San Francisco
35 protocols

Alexandros Alexandratos National and Kapodistrian University of Athens
37 protocols

Masashi Asai Yokohama University of Phrmacy
3 protocols

Ralph Boettcher Max Planck Institute for Biochemistry
47 protocols

Reviewer
Michela Perego
  • Associate staff scientist, The Wistar Institute
Research focus
  • Cancer biology
  • melanoma, cancer stem cells, slow-cycling cells, tumor dormancy, myeloid derived suppressor cells
  • 1 Author merit
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.